NGVTIngevity Corp
Chemicals & Allied Products
- Revenue
- $1.2B
- 2.7% YoY
- Operating margin
- 35.9%
- 1.0% YoY
- EBITDA
- $525M
- 1.7% YoY
- Market cap
- $2.6B
- Employees
- 1,500
- $778K revenue each
- Net debt / EBITDA
- 2.3×
- $1.2B net debt
- AI in 10-K
- 0.9
- mentions per 10K words
Takeover score 1 of 13
Fixable underperformance 0 of 7
- TSR below peersNo—3+ of last 5 years
- High CEO pay despite TSRNo—Median CEO pay ≥ $15M while TSR trails
- Earnings not backed by cashNo—Cash flow under 80% of net income
- Dilutive SBCNo2% of revenueOver 10% of revenue
- Payouts exceed cash flowNo17% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyNo0% of assetsOver 40% of assets
- Shareholder dissentNo89% lowest supportAny vote under 80% support
Buyer economics 1 of 4
- Low revenue per employeeNo$778K · 66th pctBottom quartile of its SIC industry
- Quiet on AINo0.9 per 10K words · 32nd pctBottom quartile of AI mentions in 10-Ks
- Net cashNo2.3× EBITDA net debtMore cash than debt, positive EBITDA
- Buyout-sizedYes$2.6B market capMarket cap $500M–$5B
Catalysts 0 of 2
- Active 13DNo0 filingsActive-intent 13D in 18 months
- Net insider sellingNo−$2M netNet sales over $10M in 12 months
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $1.4B | $1.7B | $1.2B | $1.2B | $1.2B | 2.7% |
| Operating income | $422M | $453M | $423M | $426M | $419M | 1.7% |
| Net income | $118M | $212M | −$5M | −$430M | −$167M | 61% |
| Operating cash flow | $293M | $313M | $205M | $129M | $331M | 158% |
| Capex | $104M | $143M | $110M | $78M | $58M | 26% |
| Stock-based comp | $12M | $16M | $11M | $12M | $18M | 54% |
| Buybacks | $109M | $145M | $92M | $0 | $56M |
Deal filings
None.
13D filers
| Filed | Filer | Form | Stake | Intent |
|---|---|---|---|---|
| Feb 28, 2024 | INCLUSIVE CAPITAL PARTNERS, L.P. | SC 13D/A | 3.2% | Active |
| May 30, 2023 | INCLUSIVE CAPITAL PARTNERS, L.P. | SC 13D/A | 6.6% | Active |
| Jul 27, 2022 | INCLUSIVE CAPITAL PARTNERS, L.P. | SC 13D/A | 5.6% | Active |
| Apr 7, 2022 | INCLUSIVE CAPITAL PARTNERS, L.P. | SC 13D | 10.8% | Active |
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $2M · 10
- Net
- −$2M
Pay vs performance
No pay-versus-performance disclosure yet.